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Objective: To evaluate the health-related quality of life (HRQL) in pediatric leprosy patients.
Methods: A cross-sectional study included 47 leprosy patients and 45 healthy subjects. The
HRQL  was measured by Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), and evaluated
physical, emotional, social and school domains. The leprosy patients were classiﬁed by
Ridley and Jopling classiﬁcation criteria and assessed according to clinical musculoskeletal
manifestations, laboratory and radiographic examinations.
Results: The median of current age was similar in leprosy patients and controls [12 (6–18)
vs.  15 (5–18) years, p = 0.384], likewise the frequencies of female gender (p = 0.835) and mid-
dle/lower Brazilian socio-economic classes (p = 1.0). The domain school activities according
the  child-self report was signiﬁcantly lower in leprosy patients compared to controls in the
age group of 13–18 years [75 (45–100) vs. 90 (45–100), p = 0.021]. The other domains were alike
in  both groups (p > 0.05). At least one musculoskeletal manifestation (arthralgia, arthritis
and/or myalgia) was observed in 15% of leprosy patients and none in controls (p = 0.012).
Further comparison between all leprosy patients showed that the median of the physical
capacity domain [81.25 (50–100) vs. 98.44 (50–100), p = 0.036] and school activities domain
by  child-self report [60 (50–85) vs. 80 (45–100), p = 0.042] were signiﬁcantly lower in patients
with musculoskeletal manifestations compared to patients without these manifestations.
No  differences were evidenced between the other HRQL parameters in both groups, reported
by  patients and parents (p > 0.05).
Conclusions: Reduced physical capacity and school activities domains were observed in pedi-atric  leprosy patients with musculoskeletal manifestations.
© 2015 Elsevier Editora Ltda. All rights reserved.
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Qualidade  de  vida  relacionada  à  saúde  avaliada  pelo  Inventário  Pediátrico
de  Qualidade  de  Vida  4.0  em  pacientes  pediátricos  com  hanseníase  e
manifestac¸ões  musculoesqueléticas
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Objetivo: Avaliar a qualidade de vida relacionada à saúde (QVRS) em pacientes pediátricos
com  hanseníase.
Métodos: Estudo transversal com 47 pacientes com hanseníase e 45 indivíduos saudáveis. A
QVRS foi mensurada pelo Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) e os domínios
físico, emocional, social e escolar foram avaliados. Os pacientes com hanseníase foram
classiﬁcados pelos critérios de Ridley e Jopling e avaliados de acordo com manifestac¸ões
clínicas musculoesqueléticas, laboratoriais e exames radiográﬁcos.
Resultados: A média de idade atual foi similar em pacientes com hanseníase e controles
[12(6-18) vs. 15(5-18) anos, p = 0,384], assim como frequências do sexo feminino (p = 0,835) e
classes socioeconômicas brasileiras média/baixa (p = 1,0). De acordo com a auto-avaliac¸ão
da  crianc¸a relacionado com as atividades escolares, este domínio foi signiﬁcativamente
menor nos pacientes com hanseníase em relac¸ão aos controles de 13-18 anos [75(45-100) vs.
90(45-100), p = 0,021]. Os outros domínios foram semelhantes em ambos os grupos (p > 0,05).
Pelo  menos uma manifestac¸ão musculoesquelética (artralgia, artrite e/ou mialgia) foi obser-
vada em 15% dos pacientes com hanseníase e nenhuma nos controles (p = 0,012). Uma
comparac¸ão  mais detalhada entre pacientes com hanseníase mostrou que a mediana do
domínio de capacidade física [81,25(50-100) vs. 98,44(50-100), p = 0,036] e de atividades esco-
lares  pela auto-avaliac¸ão da crianc¸a [60(50-85) vs. 80(45-100), p = 0,042] era signiﬁcantemente
menor nos pacientes com manifestac¸ões musculoesqueléticas em comparac¸ão com a dos
pacientes sem essas manifestac¸ões. (1) Nenhuma diferenc¸a foi evidenciada entre os outros
parâmetros de QVRS em ambos os grupos relatados pelos pacientes e pais (p > 0,05).
Conclusões: Diminuic¸ões dos domínios capacidade física e escolar foram observados em
pacientes com hanseníase pediátrica e manifestac¸ões musculoesqueléticas.
©  2015 Elsevier Editora Ltda. Todos os direitos reservados.
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eprosy, also known as Hansen’s disease, is caused by
he Mycobacterium leprae.1 This is a relevant infectious dis-
ase in developing countries. Recently in Brazil, 6.7% of
ewly detected leprosy cases were diagnosed in children and
dolescents.2
The clinical features of pediatric leprosy include several
kin lesions, numbness of the skin, damage of periph-
ral nerves, arthralgia and arthritis.3–11 In this regard, we
ecently detected that musculoskeletal manifestations were
ssociated with severe leprosy in children and adolescents,
specially in patients presenting nerve function impairment
nd neuropathy.12
Furthermore, adult leprosy patients could present reduced
cores of health-related quality of life (HRQL), particularly in
hysical capacity and social participation domains.13–17 To our
nowledge, HRQL was rarely reported in pediatric leprosy,17
nd the impact of musculoskeletal manifestations on HRQL
as not previous investigated.
Therefore, the objectives of our study were to assess
RQL in leprosy patients and healthy controls using a
eneric instrument for children/adolescents and theirs
egal guardians, and to evaluate the possible inﬂuence of
resence of musculoskeletal manifestations in decreasing
RQL.Patients  and  methods
A cross-sectional study was performed with 56 leprosy
patients, which were followed-up at the Dermatology Unit of a
tertiary hospital in Brazil. Out of them, the HRQL of 47 leprosy
patients was systematically evaluated. All patients fulﬁlled
the leprosy diagnosis according to National Leprosy Program
guidelines4 and Ridley and Jopling classiﬁcation criteria.18
Control group included 45 healthy children and adolescents
of local school in Brazil. This study was approved by the
Local Ethical Committee. Patients and controls and their legal
guardians signed the informed consent form.
Methods
Demographic  data
Demographic data included current age and gender. Brazil-
ian socio-economic classes were classiﬁed according to
the Associac¸ão Brasileira dos Institutos de Pesquisa de
Mercados.19
Clinical  assessment  of  leprosyClinical assessment of Hansen’s disease was performed
according to National Leprosy Program guidelines.4
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No differences were evidenced in middle/lower Brazilian
socio-economic classes in both groups (91% vs. 93%, p = 1.0).
Table 1 – Demographic data, classiﬁcation criteria,
clinical manifestations, laboratory, radiography and
treatments in leprosy patients.
Variables Leprosy
patients (n = 47)
Demographic data
Current age, years 12 (3–18)
Female gender 25/47 (53)
Brazilian socio economic classes
Middle/lower middles class 46 (92)
Ridley and Jopling classiﬁcation criteria
Borderline–borderline 21 (45)
Indeterminate 0 (0)
Tuberculoid 26 (55)
Lepromatous 0 (0)
World Health Organization (WHO) classiﬁcation
Multibacillary 21 (45)
Paucibacillary 26 (55)
Clinical manifestation
Hypopigmented or reddish skin
lesions with loss of sensation
47  (100)
Erythema nodosum leprosum 0 (0)
Peripheral silent neuropathy 2 (4)
Arthralgia 1 (2)
Myalgia 3 (6)
Arthritis 5 (11)
Laboratory
Autoantibodies
Antinuclear antibodies (ANA) 1 (2)
Rheumatoid factor 2/5 (20)
IgM anticardiolipin (aCL) 7 (15)
IgG aCL 1 (2)
Radiography
Joint radiographies abnormalities 0 (0)416  r e v b r a s r e u m a t
The leprosy patients were also classiﬁed by Ridley and
Jopling classiﬁcation criteria: borderline–borderline (BB),
borderline–lepromatous (BL), lepromatous–lepromatous (LL),
borderline–tuberculoid (BT), tuberculoid–tuberculoid (TT) or
indeterminate leprosy (IL).18
Clinical  musculoskeletal  manifestations
Musculoskeletal manifestations were deﬁned according to:
arthralgia (diffuse joint pain or tenderness without evidence of
inﬂammation), arthritis (swelling within a joint, or limitation
in the range of joint movement  with joint pain or tender-
ness) and myalgia (muscle pain or tenderness in one or more
limbs without evidence of inﬂammation). Arthritis were clas-
siﬁed according to the number of joints [oligoarticular (lower
or equal to 4 arthritis) and polyarticular (greater or equal to 5
arthritis)] and duration [acute (less than 6 weeks) and chronic
(over or equal to 6 weeks)], articular distribution [symmet-
ric or asymmetric], pattern of joint involvement [addictive,
migratory and intermittent] and type of joint involvement
[peripheral (large or small joints) and axial].
HRQL  assessment
The HRQL was determined by the generic instrument: Pedi-
atric Quality of Life Inventory 4.0 (PedsQL 4.0) validated to
Brazilian Portuguese language, using different versions for
three age groups 5–7, 8–12 and 13–18 years.20,21 Two instru-
ments were used in the present study: PedsQL 4.0 child-self
report and PedsQL 4.0 parents report. The PedsQL 4.0 question-
naire includes problems in four multidimensional domains
presented in the previous month, such as physical capacity,
emotional aspects, social aspects and school activities. The
23 items were scored using a ﬁve-point scale in the groups
of 8–12 years, 13–18 years and parents (0 – never, 1 – almost
never, 2 – sometimes, 3 – often and 4 – almost always) and
for children at the age of 5–7 years with a three-point scale
(0 – never, 2 – sometimes and 3 – often). The sum of the total
score varied from 0 to 100. A higher score indicated a better
HRQL.20,21
Laboratory  and  radiographic  examinations
Blinded laboratory exams were performed for the clinical
and HRQL assessments. Antinuclear antibodies (ANA) were
measured at study entry by indirect immunoﬂuorescence on
human cell epithelioma (HEp-2) cells (GMK, USA) and stain-
ing reactivity at ≥1:80. Anticardiolipin (aCL) isotypes IgG and
IgM by enzyme-linked immunosorbent assay (ELISA) (Phadia,
Sweden), cut-off value of 20 GPL and/or MPL. HLA B27 and
rheumatoid factor (RF) detections were carried out by in-house
real-time polymerise chain reaction assay (Arup Laboratories,
USA) and by immunoturbidimetric assays (Wiener, Argentina,
cut-off <20 UI/ml) respectively in patients and controls with
arthralgia and/or arthritis. Conventional joint radiographies
were carried out in patients and controls with arthralgia
and/or arthritis, and classiﬁed as: decreased joint space, ero-
sions and ankylosis. 0 1 5;5 5(5):414–419
Statistical  analysis
Statistical analyses were performed using the statistics pro-
gram SPSS. The non-parametric Mann–Whitney test was used
to compare the continuous variables and presented as median
(range). Differences in frequencies were assessed by Fisher’s
exact test for categorical variables. Values of p were set at 5%
(p < 0.05) in all statistical tests.
Results
The median of current age was similar in leprosy patients and
healthy controls [12 (6–18) vs. 15 (5–18) years, p = 0.384], like-
wise the frequencies of female gender (47% vs. 51%, p = 0.835).Treatments
Prednisone 8 (17)
Rifampicin, dapsone and clofazimin 21 (45)
Rifampicin and dapsone 26 (55)
Results are shown in media (range) and n (%).
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Table 2 – Pediatric Quality of Life Inventory 4.0 (PedsQL
4.0) scores of three age groups according to reports of
patients with leprosy and healthy controls and their
parents.
Variables Leprosy
(n  = 47)
Controls
(n  = 45)
p
5–7 years (n = 4) (n = 6)
Physical
(Patients)
100 (81–100) 98.44 (88–100) 0.719
(Parents) 98.44 (90.63–100) 98.44 (90.63–100) 1.0
Emotional
(Patients)
65 (60–80) 75 (50–90) 0.515
(Parents) 65 (60–80) 72.50 (60–85) 0.504
Social
(Patients)
85 (70–90) 82.50 (80–90) 0.909
(Parents) 95 (80–100) 90 (70–95) 0.321
School
(Patients)
95 (80–100) 75 (50–100) 0.128
(Parents) 92.50 (75–95) 67.50 (45–95) 0.130
8–12 years (n = 20) (n = 12)
Physical
(Patients)
95.94 (63–100) 100 (88–100) 0.504
(Parents) 100 (68.75–100) 100 (90.63–100) 0.982
Emotional
(Patients)
70 (55–100) 75 (45–100) 0.708
(Parents) 70 (55–100) 72.50 (65–95) 0.569
Social
(Patients)
90 (75–100) 90 (45–100) 0.270
(Parents) 95 (35–100) 100 (45–100) 0.691
School
(Patients)
80 (60–95) 85 (40–100) 0.346
(Parents) 80 (50–100) 87.50 (45–100) 0.281
13–18 years (n = 23) (n = 27)
Physical
(Patients)
93.75 (50–100) 93.75 (50–100) 0.597
(Parents) 100 (50–100) 93.75 (53.13–100) 0.179
Emotional
(Patients)
70 (30–95) 75 (40–100) 0.358
(Parents) 75 (35–100) 80 (25–100) 0.769
Social
(Patients)
90 (45–100) 95 (75–100) 0.506
(Parents) 100 (75–100) 100 (65–100) 0.631
School
(Patients)
75 (45–100) 90 (45–100) 0.021
(Parents) 80 (35–95) 80 (35–100) 0.473
t
i
c
a
c
c
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d
a
a
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Table 3 – Pediatric Quality of Life Inventory 4.0 (PedsQL
4.0) scores of children and adolescents, and their
parents according to the presence of musculoskeletal
manifestations.
Variables With
musculoskeletal
manifestations
(n  = 7)
Without
musculoskeletal
manifestations
(n  = 40)
p
Children
Physical 81.25 (50–100) 98.44 (50–100) 0.036
Emotional 65.00 (30–80) 70 (45–100) 0.270
Social 90.00 (65–100) 90 (45–100) 0.336
School 60.00 (50–85) 80 (45–100) 0.042
Parents
Physical 90.63 (50–100) 100 (68.75–100) 0.143
Emotional 65.00 (35–80) 72.50 (50–100) 0.107
Social 95.00 (80–100) 100 (35–100) 0.735
School 70 (50–95) 82.50 (35–100) 0.094
Results are presented in median (range) by Mann–Whitney test.Results are presented in median (range) by Mann–Whitney test.
Demographic data, classiﬁcation criteria, clinical manifes-
ations, laboratory abnormalities, radiography and treatments
n leprosy patients were described in Table 1.
Table 2 includes PedsQL 4.0 scores for three age groups of
hildren and adolescents with leprosy and healthy controls
nd their parents. The domain school activities according the
hild-self report was signiﬁcantly lower in leprosy patients
ompared to healthy controls in the age group of 13–18 years
75 (45–100) vs. 90 (45–100), p = 0.021] (Table 2). The other
omains were alike in both groups (p > 0.05). All domains were
lso similar in the parent evaluations (p > 0.05, Table 2).
At least one musculoskeletal manifestation (arthralgia,
rthritis and/or myalgia) was observed in 15% of leprosy
atients and none in healthy controls (p = 0.012). Five lep-
osy patients had acute or chronic peripheral, asymmetric,migratory polyarthritis of small joints of the hands (metacar-
pophalangeal and proximal interphalangeal joints), with
median duration of 12 months (ranged from 15 days to 36
months). Four of them had borderline–borderline leprosy form
and had chronic polyarthritis with morning stiffness, mimick-
ing juvenile idiopathic arthritis (JIA). ANA and HLA B27 test
were negative in all patients with arthralgia and/or arthri-
tis. RF was positive in 2 of 5 patients with arthralgia and/or
arthritis. None of them had conventional joint radiographies
abnormalities.
Further comparison between all leprosy patients showed
that the median of the physical capacity domain [81.25
(50–100) vs. 98.44 (50–100), p = 0.036] and school activities
domain by child-self report [60 (50–85) vs. 80 (45–100), p = 0.042]
were signiﬁcantly lower in patients with musculoskeletal
manifestations compared without these manifestations. No
differences were evidenced between the other HRQL parame-
ters in both groups, reported by patients and parents (p > 0.05,
Table 3).
Discussion
To our knowledge this was the ﬁrst report that studied HRQL
in pediatric leprosy patients with musculoskeletal manifes-
tations, and observed reduced scores in physical and school
domains.
The major advantage of this study was the systematic
assessment of the HRQL in children and adolescents with
leprosy in a well-known endemic area of this infectious dis-
ease in Brazil. Moreover, a healthy control group with similar
age, gender and socio-economic class was included in the
present study. The importance of these similarities observed
herein was also reported in several studies that found a rela-
tion between HRQL and low socio-economic class, gender and
age.22–24 The main limitations were the small number of lep-
rosy patients evaluated herein and the use of only one HRQL
generic instrument.
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The global prevalence of leprosy is increasing around the
world2 and continues to be high endemic in a number of
developing countries, including Brazil.3 In 2012, the propor-
tion of children and adolescents among newly detected cases
in Brazil was 6.7%.2 The main clinical involvements of leprosy
are hypo pigmented or reddish localized skin lesions with loss
of sensation and peripheral nerves involvements.3 Muscu-
loskeletal is the third most involved commonly organ/system
in adult leprosy,7 and arthritis was observed in up to 65%.6,25,26
In pediatric leprosy population, we  recently observed that
musculoskeletal manifestation was associated with nerve
dysfunction. Therefore, Hansen’s disease should be included
in the differential diagnosis of non-erosive asymmetric
arthritis.12
Moreover, the scores of HRQL may be decreased in children
and adolescents with chronic diseases comparing to healthy
subjects,27 as observed in our study. Interestingly, around 60%
of the adult patients with leprosy experienced a limitation in
the execution of daily activities and also 60% leprosy patients
had problems in social participation.16
Furthermore, adult leprosy patients presented problems in
mobility, interpersonal relationship, marriage, employment,
leisure activities and social attendance.13 In patients with
10–29 years, there was observed a lower HRQL scores compar-
ing to healthy controls, in several categories, such as psychical,
vitality, social functioning and emotional role.17
The present study investigated HRQL in three different
groups of age of pediatric leprosy using PedsQL 4.0 score. In
contrast with other questionnaires, such as SF-36 instrument,
which assesses physical and mental components in adults,
PedsQL 4.0 evaluates emotional domain and school activities,
which are relevant to the pediatric population. A signiﬁcant
lower child-reported HRQL scores was observed in pediatric
leprosy patients with musculoskeletal manifestations in com-
parison with patients without these manifestations in the
domains physical capacity and school activities. These ﬁnd-
ings could be related to neuropathy and/or articular chronic
pain with writing difﬁculties, which induces chronic health
problems and poor school performance.28 On the other hand,
no differences were evidenced in the emotional and social
domains, probably due to the predominance of skin localized
manifestations in our population, without ﬁndings of stig-
matized disease. Indeed, none of our patient had a severe
lepromatous subtype, which is characterized by nodules (lep-
romas) and a peculiar facies with diffuse inﬁltration and
eyelash loss, named leonine facies.3,4
Therefore, a detailed investigation of all leprosy patients
with musculoskeletal manifestations is required. The need to
establish preventive programs, including a multiprofessional
and a multidisciplinary team, is of the utmost importance for
this population.
In conclusion, this was the ﬁrst study to identify reduced
physical capacity and school activities domains in pediatric
leprosy patients with musculoskeletal manifestations.
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